| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/18/2011 | US7872006 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 01/18/2011 | US7872000 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 01/18/2011 | CA2511301C Acylsufonamide compounds as inhibitors of rna-dependent rna viral polymerase |
| 01/18/2011 | CA2500225C Pyrazole compounds |
| 01/18/2011 | CA2493310C 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 01/18/2011 | CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/18/2011 | CA2432077C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists |
| 01/13/2011 | WO2011005929A1 Piperidine derivative and its use for the treatment of diabets and obesity |
| 01/13/2011 | WO2011005909A2 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines |
| 01/13/2011 | WO2011005674A1 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | WO2011005119A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | WO2011005052A2 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 01/13/2011 | WO2011005029A2 Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein |
| 01/13/2011 | WO2011004972A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 01/13/2011 | WO2011004391A2 An improved process for the preparation of eletriptan and its salt thereof |
| 01/13/2011 | WO2011004276A1 Hepatitis c virus inhibitors |
| 01/13/2011 | WO2011004200A1 Novel pyrrole derivatives |
| 01/13/2011 | WO2011004132A1 Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof |
| 01/13/2011 | WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2011003796A1 Pyridazine compounds for controlling invertebrate pests |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2010116328A3 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | WO2010012442A8 Insecticidal benzenedicarboxamide derivative |
| 01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009441 Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| 01/13/2011 | US20110009440 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 01/13/2011 | US20110009437 Carboxamide-heteroaryl derivatives for the treatment of diabetes |
| 01/13/2011 | US20110009428 Novel androgens |
| 01/13/2011 | US20110009424 Co-Crystals and Pharmaceutical Compositions Comprising the same |
| 01/13/2011 | US20110009418 Therapeutic agents useful for treating pain |
| 01/13/2011 | US20110009414 Heterocyclic derivatives and their use as therapeutic agents |
| 01/13/2011 | US20110009413 Cyclic triazo and diazo sodium channel blockers |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009384 Fused ring compounds as partial agonists of ppar-gamma |
| 01/13/2011 | US20110009379 Indolinone compound |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110006295 Compounds having electroluminescent or electron transport properties |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | CA2767734A1 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 01/13/2011 | CA2767467A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | CA2767008A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | CA2766343A1 Platelet-activating factor receptor antagonists |
| 01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | CA2764173A1 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines |
| 01/12/2011 | EP2272834A1 Benzoyl amino heterocyclyl compounds as glucokinase (GLK) activators |
| 01/12/2011 | EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 01/12/2011 | EP2272827A1 Sulphonylpyrroles as hdac inhibitors |
| 01/12/2011 | EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation |
| 01/12/2011 | EP2271642A2 Pyridyl inhibitors of hedgehog signalling |
| 01/12/2011 | EP2271641A1 Fungicide hydroximoyl-heterocycles derivatives |
| 01/12/2011 | EP2271639A2 Fungicide hydroximoyl-tetrazole derivatives |
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP2271630A1 Compounds and compositions as protein kinase inhibitors |
| 01/12/2011 | EP2271629A1 Substituted pyrimidin-5-carboxamides 281 |
| 01/12/2011 | EP2081890B1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 01/12/2011 | EP2038146B1 Gas generant compositions |
| 01/12/2011 | EP1869001B1 Substituted tetrahydroisochinolines as mmp inhibitors, related production method and use as medicine |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | EP1670784B1 Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists |
| 01/12/2011 | CN101945879A Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 01/12/2011 | CN101945856A Herbicidal pyridazinone derivatives |
| 01/12/2011 | CN101941973A Benzoglioxaline-4-amide type derivative, preparation method, medical composition and application thereof |
| 01/12/2011 | CN101941965A Preparation method of candesartan cilexetil |
| 01/12/2011 | CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/12/2011 | CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry |
| 01/12/2011 | CN101941939A Polyfunctional carbazole derivative oxime ester compound and preparation method and light polymerization initiator thereof |
| 01/12/2011 | CN101333215B Method for synthesizing sunitinib alkali |
| 01/11/2011 | US7868225 Artichoke hybrid named ‘PS-H2015’ |
| 01/11/2011 | US7868204 Inhibitors of histone deacetylase |
| 01/11/2011 | US7868177 protein kinase inhibitors such as N-(4-((3-(2-(methylamino)-4-pyrimidinyl)-2-pyridinyl)oxy)-1-naphthalenyl)-1H-benzimidazol-2-amine, used for the treatment of breast cancer or rheumatoid arthritis; anticarcinogenic agents; antiarthritic agents |
| 01/11/2011 | US7868169 t-butyl ester of (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methane-sulfonylaminopyrimidin)-5-yl)-3(R)hydroxy-5-oxo-(E)-6-heptenoic acid; crystalline forms may be easier to handle and process than oil intermediates; crystallization in methanol/H2O; heating, cooling, seeding, cooling, recovering |
| 01/11/2011 | US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 01/11/2011 | US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses |
| 01/11/2011 | US7868012 3-hydroxypropylsulfamic acid {5-(4-bromophenyl)-6-[2-(5-bromoprimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-amide, used for treatment of hypertension, congestive heart failure, renal and myocardial ischemia, renal failure, ischemia, dementia, headaches, hemorrhage, Raynaud's syndrome and ulcers |
| 01/11/2011 | US7868010 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; absorbed less rapidly from mucosal surfaces, less reversible |
| 01/11/2011 | CA2536384C Cyclic derivatives as modulators of chemokine receptor activity |
| 01/11/2011 | CA2495455C Use of i.kappa.b-kinase inhibitors in pain therapy |
| 01/11/2011 | CA2492138C N-phenyl-(2r,5s)dimethylpiperazine derivative |
| 01/11/2011 | CA2456426C New mandelic acid derivatives and their use as thrombin inhibitors |
| 01/11/2011 | CA2411778C Organic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2385592C Benzamides and related inhibitors of factor xa |
| 01/06/2011 | WO2011003065A2 Pyrazolopyrimidine jak inhibitor compounds and methods |
| 01/06/2011 | WO2011002984A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands |
| 01/06/2011 | WO2011002696A1 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid |
| 01/06/2011 | WO2011002520A2 Small molecule inhibitors of parp activity |
| 01/06/2011 | WO2011002408A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia |
| 01/06/2011 | WO2011002407A1 Novel compounds for treatment of neurodegeneration associated with diseases, such as alzheimer's disease or dementia |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011002038A1 Novel diarylamine compound, and anti-aging agent, polymer composition, crosslinked rubber product and molded article thereof, and method for producing diarylamine compound |
| 01/06/2011 | WO2011001115A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011001114A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors |
| 01/06/2011 | WO2011000863A1 Sulfonamide derivatives for use in the treatment of skin conditions |
| 01/06/2011 | WO2010132684A9 Inhibitors of inv(16) leukemia |
| 01/06/2011 | WO2010104843A3 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
| 01/06/2011 | WO2009157001A3 Process for preparation of candesartan cilexetil |